서브메뉴
검색
WHO Expert Consultation on Rabies : second report
WHO Expert Consultation on Rabies : second report
상세정보
- 자료유형
- 단행본
- Control Number
- n893682762
- International Standard Book Number
- 9789241209823
- International Standard Book Number
- 9789240690943 (e-book)
- International Standard Book Number
- 9240690948 (e-book)
- Library of Congress Call Number
- RA664.R3-W67 2013eb
- Dewey Decimal Classification Number
- 636.089
- Main Entry-Corporate Name
- World Health Organization
- Physical Description
- 1 online resource (149 pages) : illustrations (some color).
- Series Statement
- WHO technical report series = 0512-3054 ; 982
- General Note
- "This report contains the collective views of an international group of experts and does not necessarily represent the decision or the stated policy of the World Health Organization"--T.p.
- Bibliography, Etc. Note
- Includes bibliographical references.
- Formatted Contents Note
- 완전내용Cover; Contents; Introduction; 1. The burden of rabies; 1.1 Methods for estimating the burden of rabies; 1.2 Estimated burden of rabies in the world; 1.2.1 Countries that are free of canine rabies; 1.2.2 Countries in which canine rabies is endemic; 1.2.3 Vampire bat rabies; 1.3 Global summary; 1.4 References; 2. Classification of lyssaviruses; 2.1 Distinguishing features of lyssaviruses; 2.2 Criteria for differentiating between lyssaviruses; 2.3 Present structure of the Lyssavirus genus; 2.4 References; 3. Pathogenesis; 3.1 References; 4. Diagnosis; 4.1 Standard case definitions for rabies.
- Formatted Contents Note
- 완전내용4.2 Clinical diagnosis4.3 Biosafety, sampling and specimen transport for laboratory diagnosis; 4.3.1 Biosafety; 4.3.2 Sampling for intra-vitam diagnosis in humans; 4.3.3 Sampling for post-mortem diagnosis in humans and animals; 4.3.4 Transport of specimens; 4.4 Laboratory techniques for post-mortem diagnosis of rabies; 4.4.1 Viral antigen detection; 4.4.2 Virus isolation; 4.4.3 Viral RNA detection; 4.5 Techniques for intra-vitam diagnosis of rabies in humans; 4.5.1 Viral antigen detection; 4.5.2 Viral antibody detection; 4.5.3 Viral RNA detection; 4.5.4 Virus isolation.
- Formatted Contents Note
- 완전내용4.6 Virus identification with molecular techniques: epidemiological considerations4.7 References; 5. Management of patients before and after death; 5.1 Rabies survivors and treatment protocols; 5.2 Clinical management of rabies patients; 5.3 Transmission via organ transplantation; 5.4 Recommendations for health care personnel and patients' family members; 5.5 Management of the bodies of patients who have died of rabies; 5.6 References; 6. Vaccines and rabies immunoglobulin for humans; 6.1 Vaccine types; 6.1.1 Cell culture and embryonated egg-based rabies vaccines; 6.1.2 Nerve tissue vaccines.
- Formatted Contents Note
- 완전내용6.2 WHO prequalification of human rabies vaccines6.3 Requirements for human rabies vaccines; 6.3.1 Potency requirements, tests and standards; 6.3.2 Characterization and evaluation of rabies vaccines; 6.4 Routes of vaccine administration; 6.5 Adverse events after active immunization; 6.6 Duration of immunity; 6.7 Rabies vaccine and full post-exposure prophylaxis failures; 6.8 Rabies immunoglobulins; 6.9 References; 7. Vaccines for animals; 7.1 Vaccine types; 7.1.1 Vaccines for domestic animals; 7.2 Potency requirements for animal rabies vaccines; 7.2.1 Inactivated animal rabies vaccines.
- Formatted Contents Note
- 완전내용7.2.2 Animal rabies vaccines for oral vaccination7.3 Safety of animal vaccines; 7.3.1 Vaccines for parenteral use; 7.3.2 Vaccines for oral use; 7.4 Parenteral rabies vaccination; 7.5 References; 8. Prevention of human rabies; 8.1 General considerations; 8.2 Pre-exposure prophylaxis; 8.3 Post-exposure prophylaxis; 8.3.1 Local treatment of wounds; 8.3.2 Categories of exposure and post-exposure prophylaxis (Annex 5); 8.3.3 WHO-recommended post-exposure prophylaxis regimens; 8.3.4 Short post-exposure prophylaxis for previously vaccinated individuals.
- Summary, Etc.
- 요약More than 99% of all human rabies deaths occur in the developing world and although effective and economical control measures are available the disease has not been brought under control throughout most of the affected countries. Given that a major factor in the low level of commitment to rabies control is a lack of accurate data on the true public health impact of the disease this report of a WHO Expert Consultation begins by providing new data on the estimated burden of the disease and its distribution in the world. It also reviews recent progress in the classification of rabies viruses rabi.
- Subject Added Entry-Topical Term
- Rabies
- Subject Added Entry-Topical Term
- Rabies Microbiology
- Subject Added Entry-Topical Term
- Rabies Prevention
- Subject Added Entry-Topical Term
- Rabies vaccines
- Subject Added Entry-Topical Term
- Rabies
- Subject Added Entry-Topical Term
- TECHNOLOGY & ENGINEERING Agriculture Animal Husbandry.
- Subject Added Entry-Topical Term
- Rabies Prevention.
- Subject Added Entry-Topical Term
- Rabies vaccines.
- Added Entry-Meeting Name
- WHO Expert Consultation on Rabies
- Additional Physical Form Entry
- Print versionOrganization, World Health. WHO Expert Consultation on Rabies: Second Report. Geneva : World Health Organization, ©2013 9789241209823
- Series Added Entry-Uniform Title
- Technical report series (World Health Organization) ; 982.
- Electronic Location and Access
- 로그인을 한후 보실 수 있는 자료입니다.
- Control Number
- joongbu:440264
MARC
008140920t20132013sz a ob 000 0 eng d■001ocn893682762
■00520151002195259.4
■006m o d
■007cr cn|||||||||
■040 ▼aE7B▼beng▼erda▼cE7B▼dOCLCO▼dEBLCP▼dDEBSZ▼dN$T▼dOCLCF▼dYDXCP
■019 ▼a869095467
■020 ▼z9789241209823
■020 ▼a9789240690943 (e-book)
■020 ▼a9240690948 (e-book)
■035 ▼a(OCoLC)893682762▼z(OCoLC)869095467
■05014▼aRA664.R3▼bW67 2013eb
■072 7▼aTEC▼x003020▼2bisacsh
■08204▼a636.089
■1102 ▼aWorld Health Organization▼eissuing body.
■24510▼aWHO Expert Consultation on Rabies ▼bsecond report▼dWorld Health Organization
■264 1▼aGeneva, Switzerland▼bWorld Health Organization▼c[2013]
■264 4▼c©2013
■300 ▼a1 online resource (149 pages) ▼billustrations (some color).
■336 ▼atext▼2rdacontent
■337 ▼acomputer▼2rdamedia
■338 ▼aonline resource▼2rdacarrier
■4901 ▼aWHO technical report series▼x0512-3054▼v982
■500 ▼a"This report contains the collective views of an international group of experts and does not necessarily represent the decision or the stated policy of the World Health Organization"--T.p.
■504 ▼aIncludes bibliographical references.
■588 ▼aDescription based on online resource; title from PDF title page (ebrary, viewed September 20, 2014).
■5050 ▼aCover; Contents; Introduction; 1. The burden of rabies; 1.1 Methods for estimating the burden of rabies; 1.2 Estimated burden of rabies in the world; 1.2.1 Countries that are free of canine rabies; 1.2.2 Countries in which canine rabies is endemic; 1.2.3 Vampire bat rabies; 1.3 Global summary; 1.4 References; 2. Classification of lyssaviruses; 2.1 Distinguishing features of lyssaviruses; 2.2 Criteria for differentiating between lyssaviruses; 2.3 Present structure of the Lyssavirus genus; 2.4 References; 3. Pathogenesis; 3.1 References; 4. Diagnosis; 4.1 Standard case definitions for rabies.
■5058 ▼a4.2 Clinical diagnosis4.3 Biosafety, sampling and specimen transport for laboratory diagnosis; 4.3.1 Biosafety; 4.3.2 Sampling for intra-vitam diagnosis in humans; 4.3.3 Sampling for post-mortem diagnosis in humans and animals; 4.3.4 Transport of specimens; 4.4 Laboratory techniques for post-mortem diagnosis of rabies; 4.4.1 Viral antigen detection; 4.4.2 Virus isolation; 4.4.3 Viral RNA detection; 4.5 Techniques for intra-vitam diagnosis of rabies in humans; 4.5.1 Viral antigen detection; 4.5.2 Viral antibody detection; 4.5.3 Viral RNA detection; 4.5.4 Virus isolation.
■5058 ▼a4.6 Virus identification with molecular techniques: epidemiological considerations4.7 References; 5. Management of patients before and after death; 5.1 Rabies survivors and treatment protocols; 5.2 Clinical management of rabies patients; 5.3 Transmission via organ transplantation; 5.4 Recommendations for health care personnel and patients' family members; 5.5 Management of the bodies of patients who have died of rabies; 5.6 References; 6. Vaccines and rabies immunoglobulin for humans; 6.1 Vaccine types; 6.1.1 Cell culture and embryonated egg-based rabies vaccines; 6.1.2 Nerve tissue vaccines.
■5058 ▼a6.2 WHO prequalification of human rabies vaccines6.3 Requirements for human rabies vaccines; 6.3.1 Potency requirements, tests and standards; 6.3.2 Characterization and evaluation of rabies vaccines; 6.4 Routes of vaccine administration; 6.5 Adverse events after active immunization; 6.6 Duration of immunity; 6.7 Rabies vaccine and full post-exposure prophylaxis failures; 6.8 Rabies immunoglobulins; 6.9 References; 7. Vaccines for animals; 7.1 Vaccine types; 7.1.1 Vaccines for domestic animals; 7.2 Potency requirements for animal rabies vaccines; 7.2.1 Inactivated animal rabies vaccines.
■5058 ▼a7.2.2 Animal rabies vaccines for oral vaccination7.3 Safety of animal vaccines; 7.3.1 Vaccines for parenteral use; 7.3.2 Vaccines for oral use; 7.4 Parenteral rabies vaccination; 7.5 References; 8. Prevention of human rabies; 8.1 General considerations; 8.2 Pre-exposure prophylaxis; 8.3 Post-exposure prophylaxis; 8.3.1 Local treatment of wounds; 8.3.2 Categories of exposure and post-exposure prophylaxis (Annex 5); 8.3.3 WHO-recommended post-exposure prophylaxis regimens; 8.3.4 Short post-exposure prophylaxis for previously vaccinated individuals.
■520 ▼aMore than 99% of all human rabies deaths occur in the developing world and although effective and economical control measures are available the disease has not been brought under control throughout most of the affected countries. Given that a major factor in the low level of commitment to rabies control is a lack of accurate data on the true public health impact of the disease this report of a WHO Expert Consultation begins by providing new data on the estimated burden of the disease and its distribution in the world. It also reviews recent progress in the classification of rabies viruses rabi.
■650 0▼aRabies
■655 0▼aElectronic books.
■650 4▼aRabies▼xMicrobiology
■650 4▼aRabies▼xPrevention
■650 4▼aRabies vaccines
■650 4▼aRabies
■650 7▼aTECHNOLOGY & ENGINEERING▼xAgriculture▼xAnimal Husbandry.▼2bisacsh
■650 7▼aRabies▼xPrevention.▼2fast▼0(OCoLC)fst01086398
■650 7▼aRabies vaccines.▼2fast▼0(OCoLC)fst01086409
■655 4▼aElectronic books.
■7112 ▼aWHO Expert Consultation on Rabies▼jissuing body.
■77608▼iPrint version▼aOrganization, World Health.▼tWHO Expert Consultation on Rabies: Second Report.▼dGeneva : World Health Organization, ©2013▼z9789241209823
■830 0▼aTechnical report series (World Health Organization)▼v982.
■85640▼3EBSCOhost▼uhttp://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=847195
■938 ▼aebrary▼bEBRY▼nebr10931298
■938 ▼aEBL - Ebook Library▼bEBLB▼nEBL1600459
■938 ▼aEBSCOhost▼bEBSC▼n847195
■938 ▼aYBP Library Services▼bYANK▼n11603915
미리보기
내보내기
chatGPT토론
Ai 추천 관련 도서
Info Détail de la recherche.
- Réservation
- 캠퍼스간 도서대출
- 서가에 없는 책 신고
- My Folder
